| Literature DB >> 28567257 |
Caiyou Chen1, Heng Wang1, Zhefan Zhang1, Shicheng Jin1, Songwei Wen1, Jianjian Ji1, Lung Wa Chung2, Xiu-Qin Dong1, Xumu Zhang1,2.
Abstract
A new class of ferrocenyl chiral bisphosphorus ligand, Wudaphos, was developed, and exhibits excellent ee and activity (ee up to 99%, TON up to 20 000) for the asymmetric hydrogenation of both 2-aryl and 2-alkyl acrylic acids through ion pair noncovalent interaction under base free and mild reaction conditions. Well-known anti-inflammatory drugs such as naproxen and ibuprofen together with the intermediate for the preparation of Roche ester and some bioactive compounds were also efficiently obtained with excellent ee. Control experiments were conducted and revealed that the ion pair noncovalent interaction and chain length played important roles.Entities:
Year: 2016 PMID: 28567257 PMCID: PMC5450526 DOI: 10.1039/c6sc01845a
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Distance dependencies of the representative noncovalent interactions
| Entry | Noncovalent interaction | Energy dependence on distance |
| 1 |
| 1/ |
| 2 |
| Complicated ∼1/ |
| 3 |
| 1/ |
Scheme 1The new ferrocenyl ligands and the corresponding model of the three hindered quadrants. L = large substituent, S = small substituent, and Ferr = ferrocene.
Scheme 2Representative drugs and chemicals featuring the α-substituted propanoic acid moiety.
Scheme 3AH of 2-substituted acrylic acids.
Scheme 4Synthesis of the ferrocenyl new bisphosphorus ligands.
Ligand effect in the asymmetric hydrogenation of 2-phenyl acrylic acid
|
| ||||
| Entry | Ligand | Conv. |
| Configuration |
| 1 |
| >99 | 84 | ( |
| 2 |
| >99 | 98 | ( |
| 3 |
| >99 | 33 | ( |
| 4 |
| >99 | 74 | ( |
| 5 |
| 67 | 57 | ( |
The reaction was conducted in a 0.1 mmol scale in 1 mL of EtOH, [Rh(NBD)2]BF4 (NBD = norbornadiene) was used as metal precursor, S/C = 100, L/Rh = 1.1 : 1, temperature = rt, H2 pressure = 1 bar, reaction time = 6 h.
Substrate conversion, determined using 1H NMR.
Enantiomeric excess of 3a, determined using chiral HPLC after treating 3a with CH2N2.
Configuration of 3a, determined by comparing the optical rotation data with those reported in the literature.
Substrate scope using Wudaphos as the ligand
|
|
|
|
The reaction was conducted in a 0.1 mmol scale in 1 mL of EtOH, [Rh(NBD)2]BF4 (NBD = norbornadiene) was used as the metal precursor, Wudaphos was used as the ligand, S/C = 100, L/Rh = 1.1 : 1, temperature = rt, H2 pressure = 1 bar, reaction time = 6 h, the configuration of all the product was determined as (S) by comparing the optical rotation data with those reported by the literature, the ee was determined via chiral HPLC after esterification with CH2N2, and the conversion of the substrates was determined using 1H NMR.
TON experiment with Wudaphos as the ligand
|
| ||||
| Entry | S/C | Time (h) | Conv. |
|
| 1 | 5000 | 6 | >99 | 98 |
| 2 | 10 000 | 12 | >99 | 97 |
|
|
|
|
|
|
The reaction was conducted in EtOH, [Rh(NBD)2]BF4 (NBD = norbornadiene) was used as the metal precursor, Wudaphos was used as the ligand, L/Rh = 1.1 : 1, temperature = rt, and H2 pressure = 50 bar.
Substrate conversion, determined via 1H NMR.
Enantiomeric excess of 3a, determined using chiral HPLC after esterification with CH2N2.
Scheme 5Synthesis of the potent inhibitors 4 and the bioactive natural product 5.
Scheme 6Control experiments for the investigation of the chain length effect and the ion pair noncovalent interaction effect.
Scheme 73D models and the predicted enantiomeric control.